Search research articles
Contact Us
Filters
Showing results (541-550 of 594) with videos related to
Page
of 60
Sort By:
Cancers
|
November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients
Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Nature Communications
|
December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics
Ming Tang, Hussein A Abbas, Marcelo V Negrao, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer
Kyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2012
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma
Lai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 27, 2025
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study
Lingzhi Hong, Alessandro Di Federico, Bolun Liu, et al.
Cancer Letters
|
June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center Study
Amgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
Tina Cascone, Boris Sepesi, Heather Y Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Nature Communications
|
January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
Xin Hu, Marcos R Estecio, Runzhe Chen, et al.
Nature Communications
|
August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Page
of 60
Search research articles
Search
Showing results (541-550 of 594) with videos related to
Sort By:
Page
of 60
Cancers
|
November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients
Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Nature Communications
|
December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics
Ming Tang, Hussein A Abbas, Marcelo V Negrao, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer
Kyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2012
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma
Lai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 27, 2025
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study
Lingzhi Hong, Alessandro Di Federico, Bolun Liu, et al.
Cancer Letters
|
June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center Study
Amgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
Tina Cascone, Boris Sepesi, Heather Y Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Nature Communications
|
January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
Xin Hu, Marcos R Estecio, Runzhe Chen, et al.
Nature Communications
|
August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Page
of 60